GALT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

GALTGalectin Therapeutics Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

GALTGalectin Therapeutics Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

GALTGalectin Therapeutics Inc

3.46· pre 3.59· delayed

Mkt cap$337.8MRevenue—Revenue—

LLYELI Lilly & Co

1,417.89· pre 1,431.46· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 5 '26delayed

GALTGalectin Therapeutics Inc

LLYELI Lilly & Co

3.46pre 3.59delayed

Price

1,417.89pre 1,431.46delayed

$337.8M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

GALT3.46vsLLY1,417.89Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GALT: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GALT 6

—Perspectum Diagnosticsunlistedsupplier

—Covance (now known as Fortrea)unlistedsupplier

—Dr. Ari Rosenbergunlistedsupplier

—Dr. Chetan Bettegowdaunlistedsupplier

2 more · GALT chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

GALT, solidLLY, dashed